Barbara Nitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Barbara Nitz has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Hermann Brenner
Cancer Prevention Graduate School, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
4 shared publications Dan Rujescu
Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
3 shared publicationsElke Raum
Division of Clinical Epidemiology & Aging Research, German Cancer Research Center (DKFZ), TP4/INF581, 69120Heidelberg, Germany
3 shared publicationsNorbert Dahmen
Department of Psychiatry, University of Mainz, Mainz, Germany
3 shared publicationsThomas Illig
Institute of Epidemiology & Genome Analysis Centre, Helmholtz Center Munich, Munich/Neuherberg, Germany
3 shared publications- Andreas Friedrich Hermann Pfeiffer
German Center for Diabetes Research (DZD), Ingolstädter Landstrasse 1, 85764 München-Neuherberg, Germany
2 shared publications
Latest Publications
- Open Access
- 2 December 2015
- Published by American Diabetes Association in Diabetes
- Vol. 65 (3) , 574-584
High-Fat Diet During Mouse Pregnancy and Lactation Targets GIP-Regulated Metabolic Pathways in Adult Male Offspring
Maternal obesity is a worldwide problem associated with increased risk of metabolic diseases in the offspring. Genetic deletion of the gastric inhibitory polypeptide (GIP) receptor (GIPR) prevents high-fat diet (HFD)–induced obesity in mice due to specific changes in energy and fat cell metabolism. We investigated whether GIP-associated pathways may be targeted by fetal programming and mimicked the situation by exposing pregnant mice to control or HFD during pregnancy (intrauterine [IU]) and lactation (L). Male wild-type (WT) and Gipr−/− offspring received control chow until 25 weeks of age followed by 20 weeks of HFD. Gipr−/− offspring of mice exposed to HFD during IU/L became insulin resistant and obese and exhibited increased adipose tissue inflammation and decreased peripheral tissue substrate utilization after being reintroduced to HFD, similar to WT mice on regular chow during IU/L. They showed decreased hypothalamic insulin sensitivity compared with Gipr−/− mice on control diet during IU/L. DNA methylation analysis revealed increased methylation of CpG dinucleotides and differential transcription factor binding of promoter regions of genes involved in lipid oxidation in the muscle of Gipr−/− offspring on HFD during IU/L, which were inversely correlated with gene expression levels. Our data identify GIP-regulated metabolic pathways that are targeted by fetal programming.
- 2 December 2015
- Published by American Diabetes Association in Diabetes
- Vol. 65 (3) , 574-584
Open AccessHigh-Fat Diet During Mouse Pregnancy and Lactation Targets GIP-Regulated Metabolic Pathways in Adult Male Offspring
Maternal obesity is a worldwide problem associated with increased risk of metabolic diseases in the offspring. Genetic deletion of the gastric inhibitory polypeptide (GIP) receptor (GIPR) prevents high-fat diet (HFD)–induced obesity in mice due to specific changes in energy and fat cell metabolism. We investigated whether GIP-associated pathways may be targeted by fetal programming and mimicked the situation by exposing pregnant mice to control or HFD during pregnancy (intrauterine [IU]) and lactation (L). Male wild-type (WT) and Gipr−/− offspring received control chow until 25 weeks of age followed by 20 weeks of HFD. Gipr−/− offspring of mice exposed to HFD during IU/L became insulin resistant and obese and exhibited increased adipose tissue inflammation and decreased peripheral tissue substrate utilization after being reintroduced to HFD, similar to WT mice on regular chow during IU/L. They showed decreased hypothalamic insulin sensitivity compared with Gipr−/− mice on control diet during IU/L. DNA methylation analysis revealed increased methylation of CpG dinucleotides and differential transcription factor binding of promoter regions of genes involved in lipid oxidation in the muscle of Gipr−/− offspring on HFD during IU/L, which were inversely correlated with gene expression levels. Our data identify GIP-regulated metabolic pathways that are targeted by fetal programming.
- 5 March 2014
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 122 (03) , P012
A high-fat diet during pregnancy and lactation targets GIP-regulated metabolic pathways in male offspring in mice
Introduction: Offspring exposed to high fat diet (HFD) during pregnancy (IU) and lactation (L) are at risk of developing obesity in adulthood. Inhibition of glucose dependent insulinotropic polypeptide receptor signaling (Gipr-/-) in mice is protective of HFD induced obesity. We reported that Gipr-/- exposed to HFD during IU/L are no longer protected from diet induced obesity in adulthood. We now tested the hypothesis if these programming effects are due to altered promoter methylation of key genes of lipid metabolism which causes a decrease in gene expression. Methods: Female GIP receptor heterozygous (Gipr+/-) mice were fed either HFD or control (C) diet prior to mating with Gipr+/- male mice and during IU/L. Male Gipr-/- offspring were kept on normal chow for 22 weeks after weaning, followed by HFD for additional 20 weeks. This resulted into Gipr-/- exposed to either C (KO Ciu-HF) or HFD (KO HFiu-HF) during IU/L and HFD later in adulthood. Wild type (WT) male mice fed C diet during IU/L and HFD in adulthood served as controls (WT Ciu-HF). At 45 weeks of age, body fat content, adipocyte size and expression and DNA-methylation of genes of fatty acid oxidation in muscle were analyzed. Results: KO HFiu-HF had increased body fat content (P < 0.05) and larger adipocytes (P < 0.005) compared to KO Ciu-HF. Gene expression of PPARα (2.45-fold) and CPT-1β (1.53-fold) was massively increased in KO Ciu-HF compared to WT Ciu-HF mice (P < 0.05), but down regulated by 45.2% for PPARα and by 41.0% for CPT-1β in KO HFiu-HF compared to KO Ciu-HF (P < 0.05) in muscle. One CpG-site for PPARα and three CpG-sites for CPT-1β showed a decrease in methylation in KO Ciu-HF compared to WT Ciu-HF and a renewed increase in KO HFiu-HF as seen in WT Ciu-HF. CpG-methylation correlated inversely with gene expression. Conclusion: HFD during IU/L induces epigenetic modifications leading to decreased peripheral fatty acid oxidation that reverses the protection of diet induced obesity in Gipr-/- mice.
- 5 March 2014
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 122 (03) , P012
A high-fat diet during pregnancy and lactation targets GIP-regulated metabolic pathways in male offspring in mice
Introduction: Offspring exposed to high fat diet (HFD) during pregnancy (IU) and lactation (L) are at risk of developing obesity in adulthood. Inhibition of glucose dependent insulinotropic polypeptide receptor signaling (Gipr-/-) in mice is protective of HFD induced obesity. We reported that Gipr-/- exposed to HFD during IU/L are no longer protected from diet induced obesity in adulthood. We now tested the hypothesis if these programming effects are due to altered promoter methylation of key genes of lipid metabolism which causes a decrease in gene expression. Methods: Female GIP receptor heterozygous (Gipr+/-) mice were fed either HFD or control (C) diet prior to mating with Gipr+/- male mice and during IU/L. Male Gipr-/- offspring were kept on normal chow for 22 weeks after weaning, followed by HFD for additional 20 weeks. This resulted into Gipr-/- exposed to either C (KO Ciu-HF) or HFD (KO HFiu-HF) during IU/L and HFD later in adulthood. Wild type (WT) male mice fed C diet during IU/L and HFD in adulthood served as controls (WT Ciu-HF). At 45 weeks of age, body fat content, adipocyte size and expression and DNA-methylation of genes of fatty acid oxidation in muscle were analyzed. Results: KO HFiu-HF had increased body fat content (P < 0.05) and larger adipocytes (P < 0.005) compared to KO Ciu-HF. Gene expression of PPARα (2.45-fold) and CPT-1β (1.53-fold) was massively increased in KO Ciu-HF compared to WT Ciu-HF mice (P < 0.05), but down regulated by 45.2% for PPARα and by 41.0% for CPT-1β in KO HFiu-HF compared to KO Ciu-HF (P < 0.05) in muscle. One CpG-site for PPARα and three CpG-sites for CPT-1β showed a decrease in methylation in KO Ciu-HF compared to WT Ciu-HF and a renewed increase in KO HFiu-HF as seen in WT Ciu-HF. CpG-methylation correlated inversely with gene expression. Conclusion: HFD during IU/L induces epigenetic modifications leading to decreased peripheral fatty acid oxidation that reverses the protection of diet induced obesity in Gipr-/- mice.
- 15 August 2011
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 12 (8) , 1099-1106
Dopamine-Related Genes and Spontaneous Smoking Cessation in Ever-Heavy Smokers
Several studies have provided evidence for associations of polymorphisms located in and near dopamine-related genes and nicotine dependence and other smoking-related phenotypes, including pharmacogenetic interactions. Aim: The purpose of the present work was to examine the association of SNPs in the DOPA decarboxylase (DDC), dopamine receptor D2 (DRD2) and dopamine transporter (SLC6A3) genes with smoking cessation in a large retrospective study featuring approximately 900 cessation events. Materials & methods: Data originated from the enrollment questionnaire of the epidemiological ESTHER study of community-dwelling adults aged 50–74 years, conducted in the German state of Saarland between July 2000 and December 2002. Restricting the analyses to subjects who reported to have regularly smoked >20 cigarettes per day at some point in their life, we used survival analysis methods to model the time from initiation of regular smoking to cessation (defined as quitting with abstinence lasting until enrollment) an...
- 15 August 2011
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 12 (8) , 1099-1106
Dopamine-Related Genes and Spontaneous Smoking Cessation in Ever-Heavy Smokers
Several studies have provided evidence for associations of polymorphisms located in and near dopamine-related genes and nicotine dependence and other smoking-related phenotypes, including pharmacogenetic interactions. Aim: The purpose of the present work was to examine the association of SNPs in the DOPA decarboxylase (DDC), dopamine receptor D2 (DRD2) and dopamine transporter (SLC6A3) genes with smoking cessation in a large retrospective study featuring approximately 900 cessation events. Materials & methods: Data originated from the enrollment questionnaire of the epidemiological ESTHER study of community-dwelling adults aged 50–74 years, conducted in the German state of Saarland between July 2000 and December 2002. Restricting the analyses to subjects who reported to have regularly smoked >20 cigarettes per day at some point in their life, we used survival analysis methods to model the time from initiation of regular smoking to cessation (defined as quitting with abstinence lasting until enrollment) an...
- 30 September 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (8) , 1448-1458
Risk gene variants for nicotine dependence in the CHRNA5–CHRNA3–CHRNB4 cluster are associated with cognitive performance
Recent studies strongly support an association of the nicotinic acetylcholine receptor gene cluster CHRNA5–CHRNA3–CHRNB4 with nicotine dependence (ND). However, the precise genotype–phenotype relationship is still unknown. Clinical and epidemiological data on smoking behavior raise the possibility that the relevant gene variants may indirectly contribute to the development of ND by affecting cognitive performance in some smokers who consume nicotine for reasons of “cognition enhancement.” Here, we tested seven single nucleotide polymorphisms (SNPs) rs684513, rs637137, rs16969968, rs578776, rs1051730, rs3743078, rs3813567 from the CHRNA5–CHRNA3–CHRNB4 gene cluster for association with ND, measures of cognitive performance and gene expression. As expected, we found all SNPs being associated with ND in three independent cohorts (KORA, NCOOP, ESTHER) comprising 5,561 individuals. In an overlapping sample of 2,186 subjects we found three SNPs (rs16969968, rs1051730, rs3743078) being associated with cognitive domains from the Wechsler‐Adult‐Intelligence Scale (WAIS‐R)—most notably in the performance subtest “object assembly” and the verbal subtest “similarities.” In a refined analysis of a subsample of 485 subjects, two of these three SNPs (rs16969968, rs1051730) were associated with n‐back task performance/Continuous Performance Test. Furthermore, two CHRNA5 risk alleles (rs684513, rs637137) were associated with CHRNA5 mRNA expression levels in whole blood in a subgroup of 190 subjects. We here report for the first time an association of CHRNA5–CHRNA3–CHRNB4 gene variants with cognition possibly mediating in part risk for developing ND. The observed phenotype–genotype associations may depend on altered levels of gene expression.
- 30 September 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (8) , 1448-1458
Risk gene variants for nicotine dependence in the CHRNA5–CHRNA3–CHRNB4 cluster are associated with cognitive performance
Recent studies strongly support an association of the nicotinic acetylcholine receptor gene cluster CHRNA5–CHRNA3–CHRNB4 with nicotine dependence (ND). However, the precise genotype–phenotype relationship is still unknown. Clinical and epidemiological data on smoking behavior raise the possibility that the relevant gene variants may indirectly contribute to the development of ND by affecting cognitive performance in some smokers who consume nicotine for reasons of “cognition enhancement.” Here, we tested seven single nucleotide polymorphisms (SNPs) rs684513, rs637137, rs16969968, rs578776, rs1051730, rs3743078, rs3813567 from the CHRNA5–CHRNA3–CHRNB4 gene cluster for association with ND, measures of cognitive performance and gene expression. As expected, we found all SNPs being associated with ND in three independent cohorts (KORA, NCOOP, ESTHER) comprising 5,561 individuals. In an overlapping sample of 2,186 subjects we found three SNPs (rs16969968, rs1051730, rs3743078) being associated with cognitive domains from the Wechsler‐Adult‐Intelligence Scale (WAIS‐R)—most notably in the performance subtest “object assembly” and the verbal subtest “similarities.” In a refined analysis of a subsample of 485 subjects, two of these three SNPs (rs16969968, rs1051730) were associated with n‐back task performance/Continuous Performance Test. Furthermore, two CHRNA5 risk alleles (rs684513, rs637137) were associated with CHRNA5 mRNA expression levels in whole blood in a subgroup of 190 subjects. We here report for the first time an association of CHRNA5–CHRNA3–CHRNB4 gene variants with cognition possibly mediating in part risk for developing ND. The observed phenotype–genotype associations may depend on altered levels of gene expression.
- 20 June 2010
- Published by Springer Nature
- p. 405-435
Inferring Multiple Corsican Limax (Pulmonata: Limacidae) Radiations: A Combined Approach Using Morphology and Molecules
- 20 June 2010
- Published by Springer Nature
- p. 405-435
Inferring Multiple Corsican Limax (Pulmonata: Limacidae) Radiations: A Combined Approach Using Morphology and Molecules
- Top Cited Papers
- 25 April 2010
- Published by Springer Nature in Nature Genetics
- Vol. 42 (5) , 448-453
Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior
Kari Stefansson and colleagues report genome-wide meta-analyses for association to smoking behaviors within the population cohorts of the ENGAGE consortium. They report three loci associated to cigarettes smoked per day. Smoking is a common risk factor for many diseases1. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P < 5 × 10−8), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 × 10−69), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 × 10−12) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 × 10−8), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence2,3,4. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).
- 25 April 2010
- Published by Springer Nature in Nature Genetics
- Vol. 42 (5) , 448-453
Top Cited PapersSequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior
Kari Stefansson and colleagues report genome-wide meta-analyses for association to smoking behaviors within the population cohorts of the ENGAGE consortium. They report three loci associated to cigarettes smoked per day. Smoking is a common risk factor for many diseases1. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P < 5 × 10−8), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 × 10−69), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 × 10−12) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 × 10−8), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence2,3,4. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).
- 18 February 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (2) , 684-690
Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction
Genetic factors contribute to the overall risk of developing nicotine addiction, which is the major cause of preventable deaths in western countries. However, knowledge regarding specific polymorphisms influencing smoking phenotypes remains scarce. In the present study we provide evidence that a common single nucleotide polymorphism (SNP) in the 5′ untranslated region of CHRM2, the gene coding for the muscarinic acetylcholine receptor 2 is associated with nicotine addiction. CHRM2 was defined as a candidate gene for nicotine addiction based on previous evidence that linked variations in CHRM2 to alcohol and drug dependence. A total of more than 5,500 subjects representative of the German population were genotyped and assessed regarding their smoking habits. The impact of three SNPs in CHRM2 on smoking behavior/nicotine addiction was investigated using logistic regression models or a quasi‐Poisson regression model, respectively. We found the T allele of SNP rs324650 to be associated with an increased risk of smoking/nicotine dependence according to three different models, the recessive models of regular or heavy smokers vs. never‐smokers (odds ratio 1.17 in both analyses) and according to the Fagerström index of nicotine addiction. In the analysis stratified by gender this association was only found in females. Our data provide further evidence that variations in CHRM2 may be associated with the genetic risk of addiction in general or with certain personality traits that predispose to the development of addiction. Alternatively, variations in CHRM2 could modulate presynaptic auto‐regulation in cholinergic systems and may thereby affect an individual's response to nicotine more specifically.
- 18 February 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (2) , 684-690
Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction
Genetic factors contribute to the overall risk of developing nicotine addiction, which is the major cause of preventable deaths in western countries. However, knowledge regarding specific polymorphisms influencing smoking phenotypes remains scarce. In the present study we provide evidence that a common single nucleotide polymorphism (SNP) in the 5′ untranslated region of CHRM2, the gene coding for the muscarinic acetylcholine receptor 2 is associated with nicotine addiction. CHRM2 was defined as a candidate gene for nicotine addiction based on previous evidence that linked variations in CHRM2 to alcohol and drug dependence. A total of more than 5,500 subjects representative of the German population were genotyped and assessed regarding their smoking habits. The impact of three SNPs in CHRM2 on smoking behavior/nicotine addiction was investigated using logistic regression models or a quasi‐Poisson regression model, respectively. We found the T allele of SNP rs324650 to be associated with an increased risk of smoking/nicotine dependence according to three different models, the recessive models of regular or heavy smokers vs. never‐smokers (odds ratio 1.17 in both analyses) and according to the Fagerström index of nicotine addiction. In the analysis stratified by gender this association was only found in females. Our data provide further evidence that variations in CHRM2 may be associated with the genetic risk of addiction in general or with certain personality traits that predispose to the development of addiction. Alternatively, variations in CHRM2 could modulate presynaptic auto‐regulation in cholinergic systems and may thereby affect an individual's response to nicotine more specifically.
- Open Access
- 1 January 2010
- Published by Springer Nature in BMC Ecology and Evolution
- Vol. 10 (1) , 85
Genetic population structure of sympatric and allopatric populations of Baltic ciscoes (Coregonus albula complex, Teleostei, Coregonidae)
Teleost fishes of the Coregonidae are good model systems for studying postglacial evolution, adaptive radiation and ecological speciation. Of particular interest is whether the repeated occurrence of sympatric species pairs results from in-situ divergence from a single lineage or from multiple invasions of one or more different lineages. Here, we analysed the genetic structure of Baltic ciscoes (Coregonus albula complex), examining 271 individuals from 8 lakes in northern Germany using 1244 polymorphic AFLP loci. Six lakes had only one population of C. albula while the remaining two lakes had C. albula as well as a sympatric species (C. lucinensis or C. fontanae).
- 1 January 2010
- Published by Springer Nature in BMC Ecology and Evolution
- Vol. 10 (1) , 85
Open AccessGenetic population structure of sympatric and allopatric populations of Baltic ciscoes (Coregonus albula complex, Teleostei, Coregonidae)
Teleost fishes of the Coregonidae are good model systems for studying postglacial evolution, adaptive radiation and ecological speciation. Of particular interest is whether the repeated occurrence of sympatric species pairs results from in-situ divergence from a single lineage or from multiple invasions of one or more different lineages. Here, we analysed the genetic structure of Baltic ciscoes (Coregonus albula complex), examining 271 individuals from 8 lakes in northern Germany using 1244 polymorphic AFLP loci. Six lakes had only one population of C. albula while the remaining two lakes had C. albula as well as a sympatric species (C. lucinensis or C. fontanae).
- 1 August 2009
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 19 (8) , 657-659
Variants in COMT and spontaneous smoking cessation: retrospective cohort analysis of 925 cessation events
Genome-wide studies have identified single nucleotide polymorphisms associated with smoking behaviour and nicotine dependence. Less is known about genetic determinants of smoking cessation, but rs4680 in COMT has recently been shown to explain a substantial proportion of the variation in cessation in the general population. We attempted to replicate the reported, clinically relevant effect in a population-based retrospective cohort analysis of 1443 ever-heavy smokers, of whom 925 had reached abstinence. In Cox regression models, neither rs4680 nor two polymorphisms nearby were associated with smoking cessation. The adjusted relative cessation rate (95% confidence interval) in rs4680 methionine carriers in reference to valine homozygotes was 0.97 (0.83–1.12). The absence of a significant effect of rs4680 in this statistically well-powered study – the 95% confidence interval even excluding the previously reported effect – highlights the need for rigorous replication efforts and suggests that rs4680 genotype should not yet be considered informative for smoking patient care.
- 1 August 2009
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 19 (8) , 657-659
Variants in COMT and spontaneous smoking cessation: retrospective cohort analysis of 925 cessation events
Genome-wide studies have identified single nucleotide polymorphisms associated with smoking behaviour and nicotine dependence. Less is known about genetic determinants of smoking cessation, but rs4680 in COMT has recently been shown to explain a substantial proportion of the variation in cessation in the general population. We attempted to replicate the reported, clinically relevant effect in a population-based retrospective cohort analysis of 1443 ever-heavy smokers, of whom 925 had reached abstinence. In Cox regression models, neither rs4680 nor two polymorphisms nearby were associated with smoking cessation. The adjusted relative cessation rate (95% confidence interval) in rs4680 methionine carriers in reference to valine homozygotes was 0.97 (0.83–1.12). The absence of a significant effect of rs4680 in this statistically well-powered study – the 95% confidence interval even excluding the previously reported effect – highlights the need for rigorous replication efforts and suggests that rs4680 genotype should not yet be considered informative for smoking patient care.
- 17 July 2009
- Published by Oxford University Press (OUP) in Journal of Molluscan Studies
- Vol. 75 (3) , 279-294
Towards a new standard in slug species descriptions: the case of Limax sarnensis Heim & Nitz n. sp. (Pulmonata: Limacidae) from the Western Central Alps
The terrestrial slug Limax sarnensis Heim & Nitz new species is described from morphological and molecular characters, based on 298 specimens from 64 localities. Detailed descriptions of coloration, reproductive anatomy, distribution and ecology are provided. The new species differs from all other sympatric congeners by a diagnostic combination of characters: variable coloration of body with unicoloured mantle; outer fields of tripartite sole light grey to nearly black, fading from posterior to anterior and from outer edges to unpigmented middle field; penis dimension in preserved specimens about one-third to half of body length; penis interior with small transverse riblets, one longitudinal interior crest, a transverse penial crest and one longitudinal interior cord; copulates on a slime thread. It is restricted to inner alpine habitats in Switzerland and northern Italy. Phylogenetic analysis of 47 Limax specimens and outgroups using 1317 nucleotides of the cytochrome c oxidase subunit I gene supports the recognition of L. sarnensis as a new species. Limax alpinus Férussac, 1822, becomes a junior synonym of Limax cinereoniger Wolf, 1803, by the designation of a neotype. Genotypic and phenotypic data are concordant with copulation (behavioural observations). The combination of morphological, genetic, ecological and behavioural data should set a new standard in slug species description.
- 17 July 2009
- Published by Oxford University Press (OUP) in Journal of Molluscan Studies
- Vol. 75 (3) , 279-294
Towards a new standard in slug species descriptions: the case of Limax sarnensis Heim & Nitz n. sp. (Pulmonata: Limacidae) from the Western Central Alps
The terrestrial slug Limax sarnensis Heim & Nitz new species is described from morphological and molecular characters, based on 298 specimens from 64 localities. Detailed descriptions of coloration, reproductive anatomy, distribution and ecology are provided. The new species differs from all other sympatric congeners by a diagnostic combination of characters: variable coloration of body with unicoloured mantle; outer fields of tripartite sole light grey to nearly black, fading from posterior to anterior and from outer edges to unpigmented middle field; penis dimension in preserved specimens about one-third to half of body length; penis interior with small transverse riblets, one longitudinal interior crest, a transverse penial crest and one longitudinal interior cord; copulates on a slime thread. It is restricted to inner alpine habitats in Switzerland and northern Italy. Phylogenetic analysis of 47 Limax specimens and outgroups using 1317 nucleotides of the cytochrome c oxidase subunit I gene supports the recognition of L. sarnensis as a new species. Limax alpinus Férussac, 1822, becomes a junior synonym of Limax cinereoniger Wolf, 1803, by the designation of a neotype. Genotypic and phenotypic data are concordant with copulation (behavioural observations). The combination of morphological, genetic, ecological and behavioural data should set a new standard in slug species description.